170 related articles for article (PubMed ID: 26776881)
1. Auranofin-loaded nanoparticles as a new therapeutic tool to fight streptococcal infections.
Díez-Martínez R; García-Fernández E; Manzano M; Martínez Á; Domenech M; Vallet-Regí M; García P
Sci Rep; 2016 Jan; 6():19525. PubMed ID: 26776881
[TBL] [Abstract][Full Text] [Related]
2. Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections.
Aguinagalde L; Díez-Martínez R; Yuste J; Royo I; Gil C; Lasa Í; Martín-Fontecha M; Marín-Ramos NI; Ardanuy C; Liñares J; García P; García E; Sánchez-Puelles JM
J Antimicrob Chemother; 2015 Sep; 70(9):2608-17. PubMed ID: 26142477
[TBL] [Abstract][Full Text] [Related]
3. BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.
Mahmoud MY; Demuth DR; Steinbach-Rankins JM
J Nanobiotechnology; 2018 Sep; 16(1):69. PubMed ID: 30219060
[TBL] [Abstract][Full Text] [Related]
4. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
Shaaban MI; Shaker MA; Mady FM
J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Cellular Cytotoxicity and Antibacterial Activity of 18-β-Glycyrrhetinic Acid by Albumin-conjugated PLGA Nanoparticles.
Darvishi B; Manoochehri S; Esfandyari-Manesh M; Samadi N; Amini M; Atyabi F; Dinarvand R
Drug Res (Stuttg); 2015 Dec; 65(12):617-23. PubMed ID: 25607747
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of clarithromycin loaded PLGA nanoparticles.
Valizadeh H; Mohammadi G; Ehyaei R; Milani M; Azhdarzadeh M; Zakeri-Milani P; Lotfipour F
Pharmazie; 2012 Jan; 67(1):63-8. PubMed ID: 22393833
[TBL] [Abstract][Full Text] [Related]
7. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
[TBL] [Abstract][Full Text] [Related]
8. Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa.
Sabaeifard P; Abdi-Ali A; Gamazo C; Irache JM; Soudi MR
J Med Microbiol; 2017 Mar; 66(2):137-148. PubMed ID: 28260589
[TBL] [Abstract][Full Text] [Related]
9. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Mistry NP; Desai JL; Thakkar HP
J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
[TBL] [Abstract][Full Text] [Related]
11. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats.
Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X
J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669
[TBL] [Abstract][Full Text] [Related]
12. Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease.
Takahashi C; Akachi Y; Ogawa N; Moriguchi K; Asaka T; Tanemura M; Kawashima Y; Yamamoto H
Med Mol Morphol; 2017 Mar; 50(1):9-16. PubMed ID: 27119723
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
Lin TsT; Gao DY; Liu YC; Sung YC; Wan D; Liu JY; Chiang T; Wang L; Chen Y
J Control Release; 2016 Jan; 221():62-70. PubMed ID: 26551344
[TBL] [Abstract][Full Text] [Related]
14. Study of antimicrobial effects of vancomycin loaded PLGA nanoparticles against enterococcus clinical isolates.
Lotfipour F; Abdollahi S; Jelvehgari M; Valizadeh H; Hassan M; Milani M
Drug Res (Stuttg); 2014 Jul; 64(7):348-52. PubMed ID: 24307271
[TBL] [Abstract][Full Text] [Related]
15. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
17. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
18. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
Girotra P; Singh SK; Kumar G
Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690
[TBL] [Abstract][Full Text] [Related]
19. Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa.
Sabaeifard P; Abdi-Ali A; Soudi MR; Gamazo C; Irache JM
Eur J Pharm Sci; 2016 Oct; 93():392-8. PubMed ID: 27575877
[TBL] [Abstract][Full Text] [Related]
20. Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.
Mura P; Maestrelli F; Cecchi M; Bragagni M; Almeida A
J Microencapsul; 2010; 27(6):479-86. PubMed ID: 20113170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
